论文部分内容阅读
美国国立癌研究所满屋裕明的研究小组成功地发现了治疗爰滋病的新药。在长崎市正在召开的卡波济肉瘤和爰滋病国际讨论会上发表了1(?)例患者的临床应用效果。这种新药具有阻止病毒增殖的作用。它不仅对病情恶化的患者有一定疗效,而且还被认为可预防感染者的发病。新药是一种称为嗜酸性脱氧胸腺嘧啶核苷的核酸合成物质的一种。满屋等从大约上百种化学物质中发现了它并改造了其部分化学结构。从去年九月开始,经6周对15例爱滋病患者用药治疗表明,被爰滋病毒破坏而减少的血中辅助 T 细胞明显增加,部分患者体重增加,病情好转。从统计学角度讲也是有效的。至于副作用,有7人感觉头痛,1人有震颤、贫血等,但都没有危险。
The team from the National Cancer Institute, Manchuria, successfully found new drugs to treat AIDS. The clinical application of 1 (?) Patients was presented at the International Symposium on Kaposi’s Sarcoma and Gonorrhea in Nagasaki City. This new drug has the effect of preventing the proliferation of the virus. Not only does it have some effect on patients who are exacerbated, but it is also thought to prevent the onset of infections. The new drug is a type of nucleic acid synthesis known as eosinophilic thymidine. Full House et al. Discovered it from about a hundred chemical substances and modified some of its chemical structures. Starting from September last year, after 15 weeks of treatment for AIDS patients after 6 weeks, the number of helper T cells in the blood decreased significantly after being destroyed by HIV was increased. Some patients gained weight and their condition improved. From a statistical point of view is also valid. As for side effects, seven felt a headache, one had tremor, anemia, etc., but none of them were dangerous.